JEAN-PIERRE JEAN ISSA
Medical Practice in Philadelphia, PA

License number
Pennsylvania MD444160
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19140

Professional information

Jean-Pierre Issa Photo 1

Professor, Temple University; Director, Fels Institute For Cancer Research And Molecular Biology, Tu School Of Medicine

Position:
Professor at Temple University
Location:
Philadelphia, Pennsylvania
Industry:
Research
Work:
Temple University - Philadelphia since 2011 - Professor


Jean-Pierre Issa Photo 2

Dr. Jean-Pierre Issa, Philadelphia PA - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
3307 N Broad St SUITE 154, Philadelphia 19140
1515 Holcombe Blvd SUITE 428, Houston 77030
(713) 792-6161 (Phone), (800) 392-1611 (Fax)
3401 N Broad St, Philadelphia 19140
(215) 707-4000 (Phone), (215) 707-4000 (Fax)
Certifications:
Internal Medicine, 1990, Medical Oncology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3307 N Broad St SUITE 154, Philadelphia 19140
3401 N Broad St, Philadelphia 19140
1515 Holcombe Blvd SUITE 428, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
Education:
Medical School
American University of Beirut / Faculty of Medicine
Good Samaritan Hospital
The Johns Hopkins Hospital


Jean-Pierre J Issa Photo 3

Jean-Pierre J Issa, Philadelphia PA

Specialties:
Oncologist
Address:
3307 N Broad St, Philadelphia, PA 19140
2450 W Hunting Park Ave, Philadelphia, PA 19129
Education:
American University of Beirut, Faculty of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Oncology (Internal Medicine)
Good Samaritan Hospital of Maryland - Residency - Internal Medicine


Jean-Pierre Issa Photo 4

Detection Of Bladder Cancer

US Patent:
8609343, Dec 17, 2013
Filed:
Mar 12, 2012
Appl. No.:
13/417642
Inventors:
Woonbok Chung - Haverford PA, US
Bogdan A. Czerniak - Houston TX, US
Jean-Pierre Issa - Philadelphia PA, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61B 5/20
US Classification:
435 614, 435 611
Abstract:
Provided are methods for detecting bladder cancer in a subject. In some aspects, methylation of one or more of MYO3A, CA10, NKX6-2, SOX11, DBC1, NPTX2, and/or A2BP1 in DNA sediment from a urine sample may be evaluated to detect the presence or absence of a bladder cancer in a human patient.